Skip to content
PeptideRank
Reviews
Menu

Handling & storage

How to inject peptides

Almost every peptide sold for self-administration is injected the same way most people already know from insulin: subcutaneously, into the fatty layer just under the skin, not into muscle. The technique below is general subcutaneous self-injection practice, plus what the evidence says about why rotating sites actually matters.

Subcutaneous injection, step by step

  1. Wash your hands

    Soap and running water, at least a minute, including between fingers and both sides of each hand. Dry with a clean paper towel before touching any supplies.

  2. Clean the injection site

    Wipe the site with an alcohol pad, starting where you plan to inject and moving outward in a circular motion. Let the skin air-dry, or wipe it dry with clean gauze — injecting through wet alcohol stings and does nothing extra for sterility.

  3. Prepare the syringe and clear air bubbles

    Hold the syringe needle-up, tap it gently to move any air bubbles to the top, and push the plunger until the dose line matches the correct amount — the amount your reconstituted vial and prescribed dose work out to, not a guess.

  4. Pinch, insert, and inject

    With your free hand, pinch about an inch (2.5 cm) of skin and fatty tissue — not muscle — between your fingers. Insert the needle fully in one quick motion, at a 90-degree angle to the skin, or a shallower 45-degree angle if you don't have much fatty tissue at that site. Release the pinch, push the plunger to deliver the full dose, then withdraw the needle at the same angle it went in.

  5. Finish and dispose of the needle safely

    Press clean gauze on the site for a few seconds if there's any bleeding. Put the needle straight into an approved sharps container — never a household trash can — and never reuse a needle or syringe for a second injection, even on yourself.

Source: MedlinePlus (National Library of Medicine), “Subcutaneous (SQ) injections,” reviewed 10/19/2025, fetched August 2026. View on medlineplus.gov.

Peptide injection sites

Three areas of the body reliably have enough fatty tissue under the skin for a subcutaneous injection, and a real FDA-approved peptide product's own patient instructions — EGRIFTA SV (tesamorelin) — name the same abdomen site and add a specific caution worth carrying to any peptide: rotate sites, and don't inject into scar tissue, a bruise, or the navel itself.

Abdomen
Below the ribs and above the hip bones, at least 2 inches (5 cm) away from the navel.
Outer thigh
The outer side of the upper thigh, away from the inner thigh and knee.
Upper arm
At least 3 inches (7.6 cm) below the shoulder and 3 inches above the elbow, on the side or back — hard to reach without help for a self-injection.

Whichever site you use, the injection spot should be healthy skin — no redness, swelling, scarring, bruising, or other damage — and each injection should land at least an inch from the last one.

Sources: MedlinePlus, “Subcutaneous (SQ) injections” (medlineplus.gov); EGRIFTA SV (tesamorelin) full prescribing information §2.1 and Patient Instructions for Use (DailyMed). Fetched August 2026.

Why rotation actually matters

Injecting the same exact spot over and over doesn't just look or feel worse over time — it changes how the drug behaves. The evidence for this comes almost entirely from insulin self-injection, which has decades more study behind it than any peptide, but the mechanism — repeated needle trauma to the same patch of subcutaneous fat — is a technique effect, not something specific to insulin.

A study of insulin-injecting patients with diabetes found lipohypertrophy — firm, raised lumps of thickened fatty tissue at overused injection sites — in roughly two out of every three patients examined, most strongly associated with reusing the same site and reusing needles rather than using a fresh one each time. The same study found that patients with lipohypertrophy needed a meaningfully higher insulin dose to get the same effect, because scarred, thickened tissue absorbs a drug erratically and less completely than healthy fat. The 2016 international consensus on injection technique (FITTER) makes site rotation and single-use needles two of its core recommendations for exactly this reason — not comfort, but consistent drug absorption.

A practical rotation pattern: pick one site (say, the abdomen) and work around it in a consistent pattern — different quadrants, spaced at least an inch apart — before moving to a different site area entirely, and give any one exact spot time to recover before returning to it.

Sources: Blanco M, Hernández MT, Strauss KW, Amaya M, “Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes,” Diabetes & Metabolism, 2013 (PMID 23886784); Frid AH, Kreugel G, Grassi G, et al., “New Insulin Delivery Recommendations,” Mayo Clinic Proceedings, 2016 (PMID 27594187). Both re-verified live against PubMed August 2026. Both studies are insulin literature, cited as the evidence base for the injection-technique question, not as peptide-specific findings.

This is general education, not your prescriber's instructions

Everything above describes how subcutaneous self-injection is generally done and what the evidence says about site rotation. It is not specific to any one peptide, it does not state a dose or a schedule, and it does not override whatever written instructions came with your actual prescription — a compounding pharmacy or prescribing clinician may have a reason to tell you something different for a specific product, and their instruction is the one to follow. Read our full medical disclaimer before acting on anything here.

Where to go next

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.